Phase IB/II study of LEE011 (CDK4/6 inhibitor) and LGX818 (BRAF Iinhibitor) in BRAF-mutant melanoma Meeting Abstract
| Authors: | Taylor, M.; Sosman, J.; Gonzalez, R.; Carlino, M. S.; Kittaneh, M.; Lolkema, M. P.; Miller, W.; Marino, A.; Zhang, V.; Bhansali, S. G.; Parasuraman, S.; Postow, M. A. |
| Abstract Title: | Phase IB/II study of LEE011 (CDK4/6 inhibitor) and LGX818 (BRAF Iinhibitor) in BRAF-mutant melanoma |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv374 |
| End Page: | iv375 |
| Language: | English |
| ACCESSION: | WOS:000346901000315 |
| DOI: | 10.1093/annonc/mdu344.2 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1086O -- Source: Wos |
